News

Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders

CINCINNATI, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Onconetix, Inc., (Nasdaq: BWV) ("Onconetix" or the “Company”) today issued the following shareholder letter from the Company's Chief Executive Officer, Dr. Neil Campbell.

12/19/2023

Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™

Transaction strengthens commercial business with addition of diagnostics product and initial focus on prostate cancer Transaction strengthens commercial business with addition of diagnostics product and initial focus on prostate cancer

12/18/2023

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is Blue Water Vaccines, Inc. (BWV) a buy, sell, or hold?

Blue Water Vaccines, Inc. (BWV) can hold. Click on Rating Page for detail.

What is Blue Water Vaccines, Inc.'s stock price?

The price of Blue Water Vaccines, Inc. (BWV) is 0.1802 and it was updated on 2024-05-20 07:01:35.

Is Blue Water Vaccines, Inc. (BWV) overvalued or undervalued?

Currently Blue Water Vaccines, Inc. (BWV) is in undervalued.

News

From:

To:

News
Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company Transaction will Advance Company's Shift in Business Strategy Aligned with Life Sciences Industry Expertise of New Leadership Team Transaction will Advance Company's Shift in Business Strategy Aligned with Life Sciences Industry Expertise of New Leadership Team Thu, Nov. 02, 2023
Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1) CINCINNATI, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Nasdaq: BWV) ("BWB" or the “Company”) today announced that it has received a letter from the Nasdaq Stock Market, LLC ("Nasdaq") stating that the Company has regained compliance with the Nasdaq Stock Market, LLC Listing Rule 5250(c)(1) (the "Rule"). Wed, Nov. 01, 2023
Blue Water Biotech Issues Letter to Shareholders CINCINNATI, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Nasdaq: BWV) ("BWB" or the “Company”) today issued the following shareholder letter from the Company's Chief Executive Officer Dr. Neil Campbell. Mon, Oct. 30, 2023
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO CINCINNATI, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Nasdaq: BWV), which is focused on developing and commercializing transformational therapies to address significant global health challenges, today announced the appointments of Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO, effective immediately. Tue, Oct. 10, 2023
Blue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-Q CINCINNATI, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”), a biotechnology and pharmaceutical company spanning multiple sectors, today announced that it received a delinquency notification letter (“Notice”) from the Listing Qualifications staff of the Nasdaq Stock Market LLC (“Nasdaq”) on August 22, 2023 due to the Company's non-compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2023 (the “Form 10 - Q”). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the “SEC”). Mon, Aug. 28, 2023

SEC Filings

SEC Filings
Blue Water Vaccines, Inc. (BWV) - 8-K/A - Current report SEC Filings 02/27/2024
Blue Water Vaccines, Inc. (BWV) - 4 SEC Filings 02/21/2024
Blue Water Vaccines, Inc. (BWV) - 3 SEC Filings 02/16/2024
Blue Water Vaccines, Inc. (BWV) - S-1 SEC Filings 02/14/2024
Blue Water Vaccines, Inc. (BWV) - PRE 14A SEC Filings 02/14/2024
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 02/13/2024
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 02/12/2024
Blue Water Vaccines, Inc. (BWV) - S-8 SEC Filings 02/01/2024
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 01/29/2024
Blue Water Vaccines, Inc. (BWV) - SC 13G/A SEC Filings 01/26/2024
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 01/19/2024
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 01/12/2024
Blue Water Vaccines, Inc. (BWV) - 3 SEC Filings 01/03/2024
Blue Water Vaccines, Inc. (BWV) - SC 13G/A SEC Filings 01/02/2024
Blue Water Vaccines, Inc. (BWV) - SC 13G SEC Filings 12/28/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 12/28/2023
Blue Water Vaccines, Inc. (BWV) - 3 SEC Filings 12/28/2023
Blue Water Vaccines, Inc. (BWV) - 8-K/A - Current report SEC Filings 12/27/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 12/21/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 12/19/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 12/18/2023
Blue Water Vaccines, Inc. (BWV) - 10-Q - Quarterly Report SEC Filings 11/17/2023
Blue Water Vaccines, Inc. (BWV) - NT 10-Q - Quarterly Report SEC Filings 11/15/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 11/02/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 10/30/2023
Blue Water Vaccines, Inc. (BWV) - 10-Q - Quarterly Report SEC Filings 10/20/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 10/18/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 10/10/2023
Blue Water Vaccines, Inc. (BWV) - 3 SEC Filings 10/10/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 10/03/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 09/22/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 09/08/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 08/28/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 08/22/2023
Blue Water Vaccines, Inc. (BWV) - NT 10-Q - Quarterly Report SEC Filings 08/15/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 08/10/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 08/03/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 08/01/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 07/31/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 07/25/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 07/21/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 07/17/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 07/11/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 07/06/2023
Blue Water Vaccines, Inc. (BWV) - SC 13D SEC Filings 06/29/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 06/28/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 06/21/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 06/14/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 06/06/2023
Blue Water Vaccines, Inc. (BWV) - 4 SEC Filings 06/01/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 05/15/2023
Blue Water Vaccines, Inc. (BWV) - 10-Q - Quarterly Report SEC Filings 05/12/2023
Blue Water Vaccines, Inc. (BWV) - 4 SEC Filings 05/11/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 05/10/2023
Blue Water Vaccines, Inc. (BWV) - EFFECT SEC Filings 05/05/2023
Blue Water Vaccines, Inc. (BWV) - POS AM SEC Filings 04/28/2023
Blue Water Vaccines, Inc. (BWV) - DEF 14A SEC Filings 04/26/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 04/25/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 04/24/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 04/20/2023
Blue Water Vaccines, Inc. (BWV) - SC 13D SEC Filings 04/13/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 04/12/2023
Blue Water Vaccines, Inc. (BWV) - 4 SEC Filings 04/12/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 03/29/2023
Blue Water Vaccines, Inc. (BWV) - 424B5 SEC Filings 03/29/2023
Blue Water Vaccines, Inc. (BWV) - EFFECT SEC Filings 03/17/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 03/13/2023
Blue Water Vaccines, Inc. (BWV) - S-3 SEC Filings 03/09/2023
Blue Water Vaccines, Inc. (BWV) - 10-K - Current report SEC Filings 03/09/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 02/16/2023
Blue Water Vaccines, Inc. (BWV) - SC 13G SEC Filings 02/14/2023
Blue Water Vaccines, Inc. (BWV) - SC 13G SEC Filings 01/31/2023
Blue Water Vaccines, Inc. (BWV) - 4 SEC Filings 01/30/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 01/17/2023
Blue Water Vaccines, Inc. (BWV) - 3 SEC Filings 01/17/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 01/09/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 01/06/2023
Blue Water Vaccines, Inc. (BWV) - SC 13G SEC Filings 01/04/2023
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 12/12/2022
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 12/06/2022
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 12/01/2022
Blue Water Vaccines, Inc. (BWV) - SC 13D SEC Filings 11/21/2022
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 11/21/2022
Blue Water Vaccines, Inc. (BWV) - 4 SEC Filings 11/21/2022
Blue Water Vaccines, Inc. (BWV) - S-8 SEC Filings 11/14/2022
Blue Water Vaccines, Inc. (BWV) - 10-Q - Quarterly Report SEC Filings 11/14/2022
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 11/10/2022
Blue Water Vaccines, Inc. (BWV) - 4 SEC Filings 11/09/2022
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 11/08/2022
Blue Water Vaccines, Inc. (BWV) - 3 SEC Filings 11/08/2022
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 10/12/2022
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 10/11/2022
Blue Water Vaccines, Inc. (BWV) - EFFECT SEC Filings 09/20/2022
Blue Water Vaccines, Inc. (BWV) - 424B4 SEC Filings 09/20/2022
Blue Water Vaccines, Inc. (BWV) - CORRESP SEC Filings 09/14/2022
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 09/12/2022
Blue Water Vaccines, Inc. (BWV) - UPLOAD SEC Filings 09/07/2022
Blue Water Vaccines, Inc. (BWV) - SC 13D SEC Filings 08/29/2022
Blue Water Vaccines, Inc. (BWV) - S-1 SEC Filings 08/29/2022
Blue Water Vaccines, Inc. (BWV) - 4 SEC Filings 08/29/2022
Blue Water Vaccines, Inc. (BWV) - 4 SEC Filings 08/24/2022
Blue Water Vaccines, Inc. (BWV) - 3 SEC Filings 08/24/2022
Blue Water Vaccines, Inc. (BWV) - 4 SEC Filings 08/23/2022
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 08/22/2022
Blue Water Vaccines, Inc. (BWV) - 4 SEC Filings 08/22/2022
Blue Water Vaccines, Inc. (BWV) - 10-Q - Quarterly Report SEC Filings 08/15/2022
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 08/11/2022
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 07/25/2022
Blue Water Vaccines, Inc. (BWV) - DEF 14A SEC Filings 07/18/2022
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 06/30/2022
Blue Water Vaccines, Inc. (BWV) - S-8 SEC Filings 06/27/2022
Blue Water Vaccines, Inc. (BWV) - 424B3 SEC Filings 06/27/2022
Blue Water Vaccines, Inc. (BWV) - S-8 SEC Filings 06/24/2022
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 06/24/2022
Blue Water Vaccines, Inc. (BWV) - 424B3 SEC Filings 06/24/2022
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 06/01/2022
Blue Water Vaccines, Inc. (BWV) - 4 SEC Filings 05/27/2022
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 05/25/2022
Blue Water Vaccines, Inc. (BWV) - EFFECT SEC Filings 05/24/2022
Blue Water Vaccines, Inc. (BWV) - EFFECT SEC Filings 05/24/2022
Blue Water Vaccines, Inc. (BWV) - 424B3 SEC Filings 05/23/2022
Blue Water Vaccines, Inc. (BWV) - S-1/A SEC Filings 05/19/2022
Blue Water Vaccines, Inc. (BWV) - 10-Q - Quarterly Report SEC Filings 05/13/2022
Blue Water Vaccines, Inc. (BWV) - S-1 SEC Filings 05/03/2022
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 04/21/2022
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 04/20/2022
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 04/19/2022
Blue Water Vaccines, Inc. (BWV) - 10-K - Current report SEC Filings 03/31/2022
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 03/22/2022
Blue Water Vaccines, Inc. (BWV) - 8-K/A - Current report SEC Filings 03/04/2022
Blue Water Vaccines, Inc. (BWV) - SC 13D SEC Filings 03/03/2022
Blue Water Vaccines, Inc. (BWV) - SC 13D SEC Filings 03/02/2022
Blue Water Vaccines, Inc. (BWV) - 8-K - Current report SEC Filings 02/24/2022
Blue Water Vaccines, Inc. (BWV) - 4 SEC Filings 02/24/2022
Blue Water Vaccines, Inc. (BWV) - 424B4 SEC Filings 02/23/2022
Blue Water Vaccines, Inc. (BWV) - 3 SEC Filings 02/23/2022
Blue Water Vaccines, Inc. (BWV) - 424B4 SEC Filings 02/22/2022
Blue Water Vaccines, Inc. (BWV) - CERT SEC Filings 02/17/2022
Blue Water Vaccines, Inc. (BWV) - 8-A12B SEC Filings 02/17/2022
Blue Water Vaccines, Inc. (BWV) - 3 SEC Filings 02/17/2022
Blue Water Vaccines, Inc. (BWV) - SEC STAFF LETTER SEC Filings 02/16/2022
Blue Water Vaccines, Inc. (BWV) - EFFECT SEC Filings 02/14/2022
Blue Water Vaccines, Inc. (BWV) - EFFECT SEC Filings 02/14/2022
Blue Water Vaccines, Inc. (BWV) - CORRESP SEC Filings 02/11/2022
Blue Water Vaccines, Inc. (BWV) - S-1/A SEC Filings 02/08/2022
Blue Water Vaccines, Inc. (BWV) - FWP SEC Filings 01/21/2022
Blue Water Vaccines, Inc. (BWV) - FWP SEC Filings 01/20/2022
Blue Water Vaccines, Inc. (BWV) - S-1/A SEC Filings 01/06/2022
Blue Water Vaccines, Inc. (BWV) - S-1/A SEC Filings 12/29/2021
Blue Water Vaccines, Inc. (BWV) - S-1/A SEC Filings 12/28/2021
Blue Water Vaccines, Inc. (BWV) - S-1/A SEC Filings 12/13/2021
Blue Water Vaccines, Inc. (BWV) - CORRESP SEC Filings 12/13/2021
Blue Water Vaccines, Inc. (BWV) - UPLOAD SEC Filings 12/09/2021
Blue Water Vaccines, Inc. (BWV) - S-1/A SEC Filings 11/29/2021
Blue Water Vaccines, Inc. (BWV) - CORRESP SEC Filings 11/29/2021
Blue Water Vaccines, Inc. (BWV) - UPLOAD SEC Filings 11/18/2021
Blue Water Vaccines, Inc. (BWV) - SEC STAFF LETTER SEC Filings 11/17/2021
Blue Water Vaccines, Inc. (BWV) - S-1/A SEC Filings 11/05/2021
Blue Water Vaccines, Inc. (BWV) - S-1/A SEC Filings 11/04/2021
Blue Water Vaccines, Inc. (BWV) - CORRESP SEC Filings 11/04/2021
Blue Water Vaccines, Inc. (BWV) - UPLOAD SEC Filings 10/21/2021
Blue Water Vaccines, Inc. (BWV) - S-1 SEC Filings 10/08/2021
Blue Water Vaccines, Inc. (BWV) - CORRESP SEC Filings 10/08/2021
Blue Water Vaccines, Inc. (BWV) - UPLOAD SEC Filings 09/17/2021
Blue Water Vaccines, Inc. (BWV) - DRS SEC Filings 08/23/2021
Blue Water Vaccines, Inc. (BWV) - D SEC Filings 07/15/2019

Press Releases

StockPrice Release
Onconetix™ chief executive officer dr. neil j. campbell issues letter to shareholders 12/19/2023
Blue water biotech acquires proteomedix as part of transformation to commercial stage oncology company; announces name change to onconetix™ 12/18/2023
Blue water biotech signs non-binding term sheet to acquire a commercial stage oncology company 11/02/2023
Blue water biotech announces it has regained compliance with nasdaq listing rule 5250(c)(1) 11/01/2023
Blue water biotech issues letter to shareholders 10/30/2023
Blue water biotech appoints dr. neil j. campbell as president and ceo and bruce harmon as cfo 10/10/2023
Blue water biotech, inc. announces notification from nasdaq related to delayed quarterly report on form 10-q 08/28/2023
Blue water biotech announces closing of warrant exercise and issuance of new warrants in a private placement for $2.7 million gross proceeds 08/03/2023
Blue water biotech announces exercise of warrants and issuance of new warrants in a private placement for $2.7 million gross proceeds 08/01/2023
Blue water biotech and knipper health join forces to distribute samples for entadfi® and zontivity® to physicians 07/31/2023
Blue water biotech teams with upscripthealth to launch telemedicine platform for benign prostatic hyperplasia asset, entadfi® 07/25/2023
Blue water biotech issues ceo shareholder letter providing update on commercial launch activities 07/17/2023
Blue water biotech teams with advantage point solutions to provide healthcare payer coverage support 07/11/2023
Blue water biotech secures license from ohio state board of pharmacy to operate as pharmaceutical wholesaler for its fda approved products 07/06/2023
Blue water biotech teams with bfw advertising to market and advertise commercial product portfolio 07/06/2023
Blue water biotech collaborates with iqvia to build medical sales representative team to market commercial product portfolio 06/21/2023
Blue water biotech expands commercial portfolio by acquiring six fda-approved drugs across various treatment areas 06/14/2023
Blue water biotech reports first quarter 2023 financial results and recent business highlights 05/12/2023
Blue water biotech to present corporate overview and entadfi® launch plan at the jmp securities life sciences conference in new york, ny 05/10/2023
Blue water biotech to participate in the american urological association annual meeting 2023 to promote benign prostatic hyperplasia treatment entadfi® 04/25/2023
Blue water vaccines announces corporate name change to blue water biotech in connection with transition into commercial-stage biotechnology company 04/24/2023
Blue water announces acquisition of entadfi®, an fda-approved benign prostatic hyperplasia asset 04/20/2023
Blue water vaccines announces signing of sponsored research agreement with the university of texas health science center at san antonio to initiate non-human primate study for live attenuated, orally delivered chlamydia vaccine 04/12/2023
Blue water vaccines reports year 2022 financial results and recent business highlights 03/09/2023
Blue water vaccines appoints seasoned commercial operations leader frank jaeger as senior vice president of marketing and business development 02/06/2023
Blue water vaccines announces partnership with abvacc for joint development of novel monkeypox and marburg vaccine candidates 02/01/2023
Blue water vaccines to present at biotech showcase 2023 during the 41st annual j.p. morgan healthcare conference week in san francisco 01/09/2023
Blue water vaccines announces institutional research coverage by two notable healthcare-focused wall street banks, receives “buy” rating from both 12/12/2022
Blue water vaccines organizes key opinion leader event to discuss unmet need for acute otitis media and pneumonia vaccine and its streptococcus pneumoniae vaccine candidate 12/06/2022
Blue water vaccines to present update on novel, live attenuated, intranasally delivered streptococcus pneumoniae vaccine to prevent acute otitis media, pneumococcal pneumonia, and invasive pneumococcal disease at the world vaccine & immunotherapy congress west coast 2022 12/01/2022
Blue water vaccines announces plans to evaluate efficacy of streptococcus pneumoniae vaccine candidate against pneumococcal pneumonia at the world vaccine congress in barcelona 10/11/2022
Blue water vaccines to present at world vaccine congress europe 2022 09/21/2022
Blue water vaccines to present at the universal influenza vaccines 2022 conference in oxford, united kingdom 08/24/2022
Blue water vaccines announces appointment of retired deloitte consulting senior managing director simon tarsh to board of directors 08/22/2022
Blue water vaccines announces exploration of its virus-like particle (vlp) platform for use in monkeypox vaccine candidate 08/17/2022
Blue water vaccines announces closing of $10 million private placement priced at-the-market under nasdaq rules 08/11/2022
Blue water vaccines announces signing of sponsored research agreement with cincinnati children's hospital medical center for s&p vaccine platform development 07/20/2022
Blue water vaccines to present at the jmp securities life science conference 06/06/2022
Blue water vaccines announces collaboration with instituto butantan for the development of bwv-101, a universal influenza vaccine candidate 05/19/2022
Blue water vaccines reports first quarter 2022 financial results and recent business developments 05/13/2022
Blue water vaccines inc. to present at h.c. wainwright global investment conference 05/12/2022
Blue water vaccines announces expanded license agreement with st. jude children's research hospital for novel bacterial vaccine platform 05/11/2022
Blue water vaccines presents new data supporting universal influenza vaccine candidate at the world vaccine congress 2022 in washington, dc 04/21/2022
Blue water vaccines announces closing of $8 million private placement priced at-the-market under nasdaq rules 04/20/2022
Blue water vaccines announces $8 million private placement priced at-the-market under nasdaq rules 04/13/2022
Blue water vaccines inc to present at world vaccine congress washington 2022 04/11/2022
Blue water vaccines announces closing of initial public offering 02/23/2022
Blue water vaccines announces pricing of approximate $20m initial public offering 02/17/2022

More Headlines

News
Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds CINCINNATI, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), today announced the closing of its previously announced exercise of certain existing warrants to purchase 2,486,214 shares of its common stock at a reduced exercise price of $1.09 per share, in exchange for new warrants as described below. The aggregate gross proceeds from the exercise of the existing warrants were approximately $2.7 million, before deducting placement agent fees and other offering expenses payable by the Company. 08/03/2023
Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds CINCINNATI, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. ("Blue Water" or the “Company”) (Nasdaq: BWV), today announced it has entered into a definitive agreement for the exercise of certain existing warrants to purchase 2,486,214 shares of its common stock at a reduced exercise price of $1.09 per share, in exchange for new warrants as described below. The aggregate gross proceeds from the exercise of the existing warrants is expected to total approximately $2.7 million, before deducting placement agent fees and other offering expenses payable by the Company. The transaction is expected to close on or about August 2, 2023, subject to satisfaction of customary closing conditions. 08/01/2023
Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to Physicians CINCINNATI, July 31, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology and pharmaceutical company focused on developing and commercializing transformational therapies to address significant health challenges globally, today announced an agreement with Knipper Health, Inc. (“Knipper Health”) to manage the inventory and distribution of product samples to sales representatives for ENTADFI® and ZONTIVITY®. 07/31/2023
Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI® CINCINNATI, July 25, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology and pharmaceutical company focused on developing and commercializing transformational therapies to address significant health challenges globally, today announced an agreement with UpScriptHealth (“UpScript”) to generate a robust, online telemedicine platform to distribute Blue Water's benign prostatic hyperplasia (“BPH”) asset, ENTADFI®. 07/25/2023
Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities CINCINNATI, July 17, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology and pharmaceutical company focused on developing and commercializing transformational therapies to address significant health challenges globally, today issued the following letter to shareholders from its Chairman and Chief Executive Officer, Joseph Hernandez. 07/17/2023
Blue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage Support Pharmaceutical consulting firm to provide Blue Water with access to healthcare payers and PBMs Pharmaceutical consulting firm to provide Blue Water with access to healthcare payers and PBMs 07/11/2023
Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products First state license is a key achievement as Blue Water continues to expand its business into commercial activities First state license is a key achievement as Blue Water continues to expand its business into commercial activities 07/06/2023
Blue Water (BWV) Up on Acquisition of 6 FDA-Approved Drugs Blue Water (BWV) soars 62% after declaring its deal to purchase six FDA-approved products for $8.5 million. The agreement will help expand the company's portfolio into cardiology and pain management. 06/15/2023
Blue Water Biotech to Present Corporate Overview and ENTADFI® Launch Plan at the JMP Securities Life Sciences Conference in New York, NY CINCINNATI, May 10, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”), a biopharmaceutical company developing transformational therapies to address significant global health challenges, today announced that Blue Water management will present at the JMP Securities Life Sciences Conference at the New York Hilton Midtown on Monday, May 15th at 3:30pm EDT. 05/10/2023
How to Trade Penny Stocks Online: Short Guide Here's some tips on how to trade penny stocks online The post How to Trade Penny Stocks Online: Short Guide appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 02/15/2023
Penny Stocks To Buy After CPI Report? 3 To Watch Today Penny stocks to watch this week. The post Penny Stocks To Buy After CPI Report? 02/14/2023
Blue Water Vaccines to Present at Biotech Showcase 2023 During the 41st Annual J.P. Morgan Healthcare Conference Week in San Francisco CINCINNATI, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced that BWV management will present at the Biotech Showcase 2023 in San Francisco, California, happening during the 41st Annual J.P. Morgan Healthcare Conference. During the presentation, management will provide a corporate overview, recent milestones and execution, and company pipeline updates. 01/09/2023
Blue Water Vaccines to Present Update on Novel, Live Attenuated, Intranasally Delivered Streptococcus pneumoniae Vaccine to Prevent Acute Otitis Media, Pneumococcal Pneumonia, and Invasive Pneumococcal Disease at the World Vaccine & Immunotherapy Congress West Coast 2022 CINCINNATI, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), today announced that Ali Fattom, Ph.D., will present at the World Vaccine & Immunotherapy Congress West Coast 2022 in San Diego, California on Thursday, December 1, 2022. Dr. Fattom will present an overview and current progress of BWV-201, a live attenuated, intranasally delivered, serotype independent Streptococcus pneumoniae vaccine candidate for the prevention of acute otitis media (“AOM”), pneumococcal pneumonia, and invasive pneumococcal disease. 12/01/2022
Blue Water Vaccines to Present at World Vaccine Congress Europe 2022 CINCINNATI, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced that the Company will host a roundtable discussion and present at the World Vaccine Congress Europe 2022 in Barcelona, Spain. 09/21/2022
Hot Penny Stocks For Your Buy List in September? 3 to Watch Here's what you need to know about trading penny stocks on August 30th The post Hot Penny Stocks For Your Buy List in September? 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 08/30/2022
Blue Water Vaccines to Present at The Universal Influenza Vaccines 2022 Conference in Oxford, United Kingdom CINCINNATI, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced that scientists from its research partner, The University of Oxford, will present at The Universal Influenza Vaccines 2022 Conference in Oxford, United Kingdom on Monday, September 5th, 2022. 08/24/2022
Monkeypox vaccine plans lead to stock jump for Blue Water Vaccines After announcing that it plans to potentially develop a monkeypox vaccine, Blue Water Vaccines shares are surging. 08/17/2022
BWV Stock Soars as Blue Water Vaccines Explores Monkeypox Vaccine Source: angellodeco / Shutterstock.com Blue Water Vaccines (NASDAQ: BWV ) stock is rocketing higher on Wednesday after the company announced it will explore the possibility of making a monkeypox vaccine. According to a press release from the company, it intends to use its norovirus shell and protrusion (S&P) virus-like particle (VLP) platform for this. 08/17/2022
7 Short-Squeeze Stocks to Put on Your Must-Watch List The beaten-down stock market has created an opportunity for contrarian investors in short-squeeze stocks. Essentially, bearish traders must borrow the underlying securities which they are pessimistic about. 08/16/2022
What Is Going on With Blue Water Vaccines (BWV) Stock Today? Source: shutterstock.com/PhotobyTawat Blue Water Vaccines (NASDAQ: BWV ) stock is jumping more than 50% today despite having no news to offer. Based in Cincinnati, the company works on vaccines for flu and pneumonia. 07/27/2022
Blue Water Vaccines to Present at the JMP Securities Life Science Conference CINCINNATI, June 06, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced that Joseph Hernandez, Chairman and Chief Executive Officer of BWV, will present at the JMP Securities Life Science Conference. Mr. Hernandez will present a corporate overview and update for BWV's vaccine candidate pipeline. 06/06/2022
Blue Water Vaccines: Estimates And Expectations Blue Water Vaccines has a long road ahead of it. The company has multiple drug candidates in its pipeline but has not yet started clinical trials. 05/17/2022
Blue Water Vaccines Inc. to Present at H.C. Wainwright Global Investment Conference CINCINNATI, May 12, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced that Erin Henderson, Chief Business Officer of Blue Water Vaccines, will present at the H.C. Wainwright Global Investment Conference. The presentation will be available for on-demand webcast viewing starting on Wednesday, May 25, 2022, at 9:00am EDT. 05/12/2022
5 Stocks Halted In Wednesday's Session: Here's Why A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It is a measure put in place to help restore and bring order to the markets. 05/11/2022
Why Is Blue Water Vaccines (BWV) Stock Up Today? Blue Water Vaccines turned heads as BWV stock shot up more than 90% with no apparent news. What's going on with BWV stock? 05/03/2022
Blue Water Vaccines Inc to Present at World Vaccine Congress Washington 2022 CINCINNATI, April 11, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced that Brian Price, Ph.D., Head of Technology Strategy, will deliver a presentation during the World Vaccine Congress 2022 in Washington, DC. BWV will present on its universal influenza vaccine candidate, which utilizes the exclusively licensed epitopes of limited variability identified by scientists at The University of Oxford. 04/11/2022
U.S. IPO Weekly Recap: The IPO Market's Micro-Cap Run Continues With 2 Small Healthcare Deals U.S. IPO Weekly Recap: The IPO Market's Micro-Cap Run Continues With 2 Small Healthcare Deals 02/18/2022

Unlock

BWV Ratings Summary

BWV Quant Ranking